The Collaborative immunology CRO
Enriching your team
We can tell your molecule’s story
Our mission is to unlock discoveries and develop solutions for biopharmaceutical companies seeking to overcome substantial scientific challenges by providing data of outstanding quality
A transformational, inducible cell system that allows selection of the safest and most efficacious targeted therapies. IndEx-2 is an in vitro cell-based platform that provides inducible expression of any target antigen of interest (TAOI).
IndEx-2 is an effective tool that can be used to enhance a pre-clinical data package with information that offers a more comprehensive understanding of a targeted drug mechanism of action and functional profile.
Read our latest news and browse our scientific resource articles
Explore our research poster as we analyse the data from our new cell line development platform, IndEx-2.
Explore our research poster modelling the tumour microenvironment featuring NK cells, macrophages and T cells.
Find out more about our new inducible cell line development model IndEx-2 by reading through our latest whitepaper.
In this webinar, we present our own human in vitro T cell exhaustion model that is suitable for the screening of immuno-modulatory molecules, bispecific T cell engagers and multi-functional modalities.